Swiss Lonza confirms interest in US-based Capsugel

摘要

SINGAPORE (ICIS)--Lonza has expressed "strong interest" in the US-based drug capsules maker Capsugel but said that it is uncertain as to whether an acquisition will be completed, the Swiss chemicals firm said on Monday. “Lonza Group Ltd notes the recent press speculations that it is in final negotiations with Kohlberg Kravis Roberts (KKR) regarding the potential acquisition of Capsugel,” it said in a statement.